1. Home
  2. BDL vs SCLX Comparison

BDL vs SCLX Comparison

Compare BDL & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

HOLD

Current Price

$29.60

Market Cap

62.6M

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.15

Market Cap

52.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDL
SCLX
Founded
1959
2011
Country
United States
United States
Employees
N/A
30
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.6M
52.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
BDL
SCLX
Price
$29.60
$6.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1K
34.0K
Earning Date
05-18-2026
04-10-2026
Dividend Yield
1.86%
N/A
EPS Growth
49.72
N/A
EPS
0.43
N/A
Revenue
$205,248,000.00
N/A
Revenue This Year
N/A
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
$68.84
N/A
Revenue Growth
8.99
N/A
52 Week Low
$22.61
$3.60
52 Week High
$35.98
$34.27

Technical Indicators

Market Signals
Indicator
BDL
SCLX
Relative Strength Index (RSI) 39.87 38.22
Support Level $29.56 $6.20
Resistance Level $33.12 $7.76
Average True Range (ATR) 0.82 0.67
MACD -0.41 -0.02
Stochastic Oscillator 2.70 58.00

Price Performance

Historical Comparison
BDL
SCLX

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: